Peregrine Capital Management LLC Care Dx, Inc. Transaction History

Peregrine Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 17, 2020	SELL	$13.94 - $28.25 $8.83 Million - $17.9 Million	-633,282 Closed	0 $0
Q4 2019 Jan 16, 2020	BUY	$19.24 - $28.41 $710,783 - $1.05 Million	36,943 Added 6.19%	633,282 $13.7 Million
Q3 2019 Oct 16, 2019	BUY	$20.03 - $40.08 $3.09 Million - $6.18 Million	154,167 Added 34.87%	596,339 $13.5 Million
Q2 2019 Jul 18, 2019	SELL	$25.78 - $39.77 $1.28 Million - $1.97 Million	-49,524 Reduced 10.07%	442,172 $0
Q1 2019 Apr 12, 2019	SELL	$22.09 - $39.21 $1.57 Million - $2.79 Million	-71,184 Reduced 12.65%	491,696 $0
Q4 2018 Jan 17, 2019	SELL	$19.89 - $30.02 $580,807 - $876,614	-29,201 Reduced 4.93%	562,880 $14.2 Million
Q3 2018 Oct 18, 2018	BUY	$12.1 - $28.85 $7.16 Million - $17.1 Million	592,081 New	592,081 $0

218

51.1M

97.3K

43.3K

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.26B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Peregrine Capital Management LLC with notifications on news.